Dova Pharmaceuticals Inc. (DOVA)

16.02
NASDAQ : Health Technology
Prev Close 16.05
Day Low/High 15.95 / 16.19
52 Wk Low/High 5.62 / 26.49
Avg Volume 348.90K
Exchange NASDAQ
Shares Outstanding 28.23M
Market Cap 453.14M
EPS -2.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

DOVA: Insiders Vs. Shorts

DOVA: Insiders Vs. Shorts

The most recent short interest data was recently released for the 02/15/2019 settlement date, and Dova Pharmaceuticals Inc is one of the most shorted stocks of the Russell 3000, based on 20.09 "days to cover" versus the median component at 5.03. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Dova Pharmaceuticals Is Now Oversold (DOVA)

Dova Pharmaceuticals Is Now Oversold (DOVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Dova Pharmaceuticals Is Now Oversold (DOVA)

Dova Pharmaceuticals Is Now Oversold (DOVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Dova Pharmaceuticals Is Now Oversold (DOVA)

Dova Pharmaceuticals Is Now Oversold (DOVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Will Insiders Be Tempted To Buy More DOVA At The New 52-Week Low?

Will Insiders Be Tempted To Buy More DOVA At The New 52-Week Low?

In trading on Friday, shares of Dova Pharmaceuticals Inc touched a new 52-week low of $20.40/share. That's a $16.60 share price drop, or -44.86% decline from the 52-week high of $37.00 set back on 02/20/2018.

Dova Pharmaceuticals Enters Oversold Territory (DOVA)

Dova Pharmaceuticals Enters Oversold Territory (DOVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insiders Are Buying These 2 Stocks Now

Insiders Are Buying These 2 Stocks Now

Here are a couple of names that have piqued my curiosity over the past few weeks.

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

Dova Pharmaceuticals Becomes Oversold (DOVA)

Dova Pharmaceuticals Becomes Oversold (DOVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Dova Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Operating And Financial Results

Dova Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Operating And Financial Results

Conference call scheduled for 4:30 p.m. EST today